Efficacy and Safety Study of VB-1953 Topical Gel for Inflammatory Facial Acne Vulgaris

NCT03900676 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

480

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: VB-1953 - 2%
DRUG: VB-1953 - 0% (Vehicle)

Sponsor

Vyome Therapeutics Inc.